UCSF

Tagged: Bioinformatics (Biological and Medical Informatics Graduate Program)

UCSF School of Pharmacy leads in NIH funding for 36th year in a row

For the 36th consecutive year, the UCSF School of Pharmacy has received more funding from the National Institutes of Health (NIH) than any other pharmacy school in the United States.

Ahituv Lab research finds how bats grow wings, with implications for human limb development

Researchers in the laboratory of UCSF School of Pharmacy faculty member Nadav Ahituv, PhD, study the roles of gene regulatory elements—DNA segments that tell genes when, where, and to what extent to turn on and off—including in human conditions ranging from limb malformations to epilepsy and autism.

Ahituv, Kaiser Permanente study identifies genetic susceptibility for hernia

Research in the lab of UCSF School of Pharmacy faculty member Nadav Ahituv, PhD, in collaboration with the Kaiser Permanente Division of Research and others, has identified variations at four locations in the genome underlying risk for the most common type of abdominal hernia.

The Right Dose: How pharmacy researchers are making medicine more precise

Reprinted courtesy of UCSF Magazine.

In the pediatric bone marrow transplant clinic, pharmacist Janel Boyle’s past and present collide.

She drifts past young patients—many of them infants and toddlers—and notes their beaming smiles and balding heads. Her gaze shifts to the parents, their expressions tense but hopeful.

Shoichet study sheds light on “dark” cell receptors, potential drug targets

More than a quarter of all drugs work by targeting one of a large family of proteins called G-protein-coupled receptors (GPCRs). Hundreds of different GPCRs are embedded in cell membranes, converting stimuli from the outside world—neurotransmitters, hormones, even light—into intracellular signals that can change cell behavior.

Giacomini to lead largest study of genetic, ethnic differences in effectiveness of leading diabetes drug

In people with type 2 diabetes, the body is less able to use the hormone insulin to regulate blood sugar. The disease affects 350 million patients globally—including 29 million in the United States, where it is the leading cause of blindness, kidney failure, and non-accident-related amputations.

Update from the Dean - Fall/Winter 2015

Strategic planning; Recently received research funding: cancer, Alzheimer's, HIV, type 2 diabetes (Kroetz, Keiser, Gross, Roy); Recent faculty publications: fibrosis, biofilms, gout (DeGrado, Yang, Giacomini); Collaborations and partnerships; Patient care: SB 493, scope of practice for California pharmacists; Education: Precision Medicine Student Alliance; New PharmD curriculum development; Faculty honors: Abate, Benet, Burchard, Desai, MacDougall, Wells, Yokoyama; Alumni honors: Levin, Schweitzer; New faculty members: Clinard, Buening, Toy, Seiple; Appointments: Jacobson, Sali; New development colleagues: Clark, Dalfen; “Making History” event; Global health: Apoteko Retreat; Campus: King; Hygeia sculpture.

Desai elected to the National Academy of Medicine

UCSF School of Pharmacy faculty member Tejal Desai, PhD, has been newly elected to the National Academy of Medicine (NAM), formerly known as the Institute of Medicine (IOM).

NAM membership is considered one of the highest honors in health and medicine. Elected by current members, the membership recognizes individuals who have made major contributions to the advancement of the medical sciences, health care, and public health.

Fischbach joins project to generate drugs from bacterial genomes

Bacteria generate small molecules to fend off their fellow microbes. They also produce molecules that affect the response of host organisms—including humans—to their presence. Such molecules have been a major source of antibiotics, immunosuppressants, anti-cancer agents, and other drugs. But their discovery has not been systematic and the products of bacteria living in our bodies have only recently drawn scientific notice.

Pages